Improving the view: the need for global action on universal access to cancer imaging

Affiliations

Comment

Katherine Gourd et al. Lancet Oncol. 2021 Apr.

. 2021 Apr;22(4):422-423.

doi: 10.1016/S1470-2045(21)00093-0. Epub 2021 Mar 4.

No abstract available

Comment on

Medical imaging and nuclear medicine: a Lancet Oncology Commission.
Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, Ward ZJ, Scott AM. Hricak H, et al. Lancet Oncol. 2021 Apr;22(4):e136-e172. doi: 10.1016/S1470-2045(20)30751-8. Epub 2021 Mar 4. Lancet Oncol. 2021. PMID: 33676609 Free PMC article. Review.

Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients.
Alberts I, Sari H, Mingels C, Afshar-Oromieh A, Pyka T, Shi K, Rominger A. Alberts I, et al. Cancer Imaging. 2023 Mar 18;23(1):28. doi: 10.1186/s40644-023-00540-3. Cancer Imaging. 2023. PMID: 36934273 Free PMC article. Review.
Comparing the clinical performance and cost efficacy of [⁶⁸Ga]Ga-PSMA-11 and [¹⁸F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis.
Alberts I, Mingels C, Zacho HD, Lanz S, Schöder H, Rominger A, Zwahlen M, Afshar-Oromieh A. Alberts I, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4252-4261. doi: 10.1007/s00259-021-05620-9. Epub 2021 Nov 13. Eur J Nucl Med Mol Imaging. 2022. PMID: 34773473 Free PMC article.